HCW Biologics Inc. (HCWB)
Largest Insider Buys in Sector
HCWB Stock Price History Chart
HCWB Stock Performance
About HCW Biologics Inc.
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
Insider Activity of HCW Biologics Inc.
Over the last 12 months, insiders at HCW Biologics Inc. have bought $69,856 and sold $0 worth of HCW Biologics Inc. stock.
On average, over the past 5 years, insiders at HCW Biologics Inc. have bought $2.97M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Byam Rebecca (Chief Financial Officer) — $60,807. Winer Gary M (director) — $10,617. Wong Hing C (Chief Executive Officer) — $3,741.
The last purchase of 1,800 shares for transaction amount of $3,741 was made by Wong Hing C (Chief Executive Officer) on 2023‑09‑14.
List of Insider Buy and Sell Transactions, HCW Biologics Inc.
| 2023-09-14 | Wong Hing C | Chief Executive Officer | 1,800 0.0049% | $2.08 | $3,741 | -43.66% | ||
| 2023-09-14 | Winer Gary M | director | 1,041 0.0028% | $2.05 | $2,139 | -43.66% | ||
| 2023-09-13 | Byam Rebecca | Chief Financial Officer | 5,000 0.0144% | $2.10 | $10,490 | -40.59% | ||
| 2023-09-13 | Winer Gary M | director | 546 0.0015% | $2.05 | $1,117 | -40.59% | ||
| 2023-09-12 | Byam Rebecca | Chief Financial Officer | 5,000 0.0143% | $2.09 | $10,442 | -40.89% | ||
| 2023-09-12 | Winer Gary M | director | 500 0.0014% | $2.05 | $1,025 | -40.89% | ||
| 2023-09-11 | Byam Rebecca | Chief Financial Officer | 5,000 0.0145% | $2.05 | $10,273 | -39.09% | ||
| 2023-09-11 | Winer Gary M | director | 99 0.0003% | $2.05 | $203 | -39.09% | ||
| 2023-09-08 | Byam Rebecca | Chief Financial Officer | 5,000 0.0137% | $2.02 | $10,111 | -40.49% | ||
| 2023-09-08 | Winer Gary M | director | 1 <0.0001% | $1.90 | $2 | -40.49% | ||
| 2023-09-07 | Byam Rebecca | Chief Financial Officer | 5,000 0.0139% | $1.95 | $9,742 | -36.41% | ||
| 2023-09-07 | Winer Gary M | director | 63 0.0002% | $1.95 | $123 | -36.41% | ||
| 2023-09-06 | Byam Rebecca | Chief Financial Officer | 5,000 0.0144% | $1.95 | $9,749 | -34.26% | ||
| 2023-09-05 | Winer Gary M | director | 400 0.0011% | $1.75 | $700 | -36.15% | ||
| 2023-06-09 | Byam Rebecca | Chief Financial Officer | 20,000 0.057% | $2.06 | $41,286 | -21.04% | ||
| 2023-06-08 | Byam Rebecca | Chief Financial Officer | 4,696 0.0135% | $2.21 | $10,388 | -25.58% | ||
| 2023-06-08 | Flowers Lee | SVP of Business Development | 10,000 0.028% | $2.16 | $21,574 | -25.58% | ||
| 2023-06-07 | Byam Rebecca | Chief Financial Officer | 20,000 0.0542% | $2.03 | $40,632 | -23.37% | ||
| 2023-06-06 | Byam Rebecca | Chief Financial Officer | 19,062 0.0524% | $1.82 | $34,779 | -13.51% | ||
| 2023-06-05 | Byam Rebecca | Chief Financial Officer | 20,000 0.054% | $1.67 | $33,344 | -6.98% |
Insider Historical Profitability
| Wong Hing C | Chief Executive Officer | 15314868 42.5713% | $0.74 | 14 | 0 | <0.0001% |
| Byam Rebecca | Chief Financial Officer | 573946 1.5954% | $0.74 | 22 | 0 | <0.0001% |
| Winer Gary M | director | 17000 0.0473% | $0.74 | 11 | 0 | +1.65% |
| GARRETT SCOTT T | director | 125000 0.3475% | $0.74 | 1 | 0 | <0.0001% |
| Flowers Lee | SVP of Business Development | 111308 0.3094% | $0.74 | 5 | 0 | <0.0001% |
| Rhode Peter | See Remarks | 46785 0.1301% | $0.74 | 1 | 0 | <0.0001% |
| Jiao Jin-an | VP of Development | 30571 0.085% | $0.74 | 1 | 0 | <0.0001% |
| Greene Rick S. | 8411 0.0234% | $0.74 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| Avantax Planning Partners | $314,610.00 | 0.48 | 179,777 | +0.13% | +$413.00 | 0.01 | |
| Hightower Advisors | $316,000.00 | 0.48 | 179,810 | 0% | +$0 | <0.01 | |
| Geode Capital Management | $291,132.00 | 0.46 | 174,284 | +29.64% | +$66,563.93 | <0.0001 | |
| Cresset Asset Management Llc | $230,983.00 | 0.35 | 131,990 | 0% | +$0 | <0.01 | |
| Bridgeway Capital Management | $141,449.00 | 0.22 | 84,700 | 0% | +$0 | <0.01 | |
| Hrt Financial Llc | $122,000.00 | 0.19 | 73,113 | New | +$122,000.00 | <0.01 | |
| BlackRock | $80,560.00 | 0.12 | 46,034 | -2.38% | -$1,967.01 | <0.0001 | |
| The Vanguard Group | $65,886.00 | 0.1 | 37,649 | -81.65% | -$293,113.86 | <0.0001 | |
| AE Wealth Management LLC | $52,500.00 | 0.08 | 30,000 | 0% | +$0 | <0.01 | |
| Two Sigma | $39,620.00 | 0.06 | 22,640 | 0% | +$0 | <0.0001 | |
| State Street | $35,815.00 | 0.06 | 21,446 | 0% | +$0 | <0.0001 | |
| Jane Street Capital | $30,182.00 | 0.05 | 17,247 | New | +$30,182.00 | <0.0001 | |
| Northern Trust | $17,859.00 | 0.03 | 10,205 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $8,642.00 | 0.01 | 4,938 | -12.89% | -$1,279.32 | <0.0001 | |
| UBS | $1,059.00 | <0.01 | 605 | -4.72% | -$52.51 | <0.0001 | |
| Bank of America | $710.00 | <0.01 | 406 | +3,590.91% | +$690.76 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 244 | -17.57% | -$0 | <0.0001 | |
| JPMorgan Chase | $15.00 | <0.01 | 9 | -89.16% | -$123.33 | <0.0001 | |
| Wells Fargo | $247.00 | <0.01 | 141 | +2.17% | +$5.25 | <0.0001 |